Sutro Biopharma STRO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$153.6M+19.6% | -$191.09M+11.8% | -$216.77M-3.9% | -$208.7M+14.9% | -$245.22M-7.8% | ||
| $6.7M-8.5% | $7.32M-3.2% | $7.57M+1.4% | $7.47M+1.5% | $7.36M+1.9% | ||
| $10.03M-28.4% | $14.01M-23.3% | $18.27M-21.5% | $23.26M-3.7% | $24.16M-2.1% | ||
| -$151.61M+14.5% | -$177.23M+20.4% | -$222.53M+10.6% | -$248.86M-21.9% | -$204.14M-1.6% | ||
| —— | —— | —— | —— | —— | ||
| $16.01M-64.4% | $45.01M-60.4% | $113.8M-48.5% | $221.1M+60.0% | $138.15M-36.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | $0— | —— | —— | —— | ||
| —— | —— | —— | —— | $97.57M+3.7% | ||
| -$34.45M+74.3% | -$134.08M-21.3% | -$110.55M-313% | -$26.76M-165% | $41.01M-66.1% | ||
| -$151.59M+14.5% | -$177.24M+20.4% | -$222.6M+10.8% | -$249.43M-21.8% | -$204.71M-1.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Sutro Biopharma generate?
- Sutro Biopharma (STRO) generated -$151.6M in operating cash flow over the trailing twelve months.
- What is Sutro Biopharma's free cash flow?
- After $627.0K of capital expenditures, Sutro Biopharma's free cash flow was -$151.6M over the trailing twelve months, up 25.9% year over year.
- Where does Sutro Biopharma's cash flow data come from?
- Every line is extracted from Sutro Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
